Food and Drug Law Weekly

Chronogen, Inc. - New management appointments named at drug discovery firm

Cincinnati Children's Hospital - LSBC enters research phase for development of atherosclerosis therapeutic

Cold Spring Harbor Laboratory - Adding drug to standard chemo improves treatment

Complementary & Alternative Medicine - More breast cancer patients seeking little-understood CAM therapies

Complementary & Alternative Medicine - Utah company guarantees nutritional supplements free of banned substances

Compound Therapeutics, Inc. - Protein-based drug developer acquires assets of Phylos

Connetics Corporation - Dermatology company completes Soriatane acquisition

Dental Health - Juneau dentists want fluoride back in water

EUROPA Steering Committee - Perindopril reduces cardiovascular death and heart attack risk in diabetes study

Faculty of Pharmacy, Barcelona - Hepatitis A peptide covalently linked to liposomes

Federal University of Rio Grande do Sul - Novel E. coli system facilitates mycobacterial protein production

GP Surgical - FDA approves TiMESH for hernia repair

German Cancer Research Center - Research leads to hope of a new treatment approach for paralysis

HIV/AIDS - U.N. plan to treat HIV/AIDS sufferers endangered by lack of money

Hannover Medical School - Beta-blocker treatment feasible for many asthma, COPD patients

Healthcare Costs - Louisiana still in limbo over use of healthcare dollars

Hollis-Eden Pharmaceuticals, Inc. - Data presented on molecular mechanism of action for HE2000

Hythiam, Inc. - Michel A. Sucher, MD, named VP clinical affairs of addiction-treatment company

INSERM EMI-U 00.18, Angiers - Food restriction affects energy metabolism in rat liver mitochondria

INSERM, Paris - IFN-alpha with ribavirin can suppress virus-specific immunity

IVAX Corp. - Company receives approval for Paxene in Europe

Influenza - Global flu outbreak could be curbed by worldside stockpile of antiviral drugs

Johns Hopkins University - Self-reported hepatitis B vaccination status unreliable among drug users

Praecis Pharmaceuticals Incorporated - Phase I clinical trial of PPI-2458 in non-Hodgkin lymphoma on hold

Taro Pharmaceutical Industries Ltd. - Phenytoin Oral Suspension receives FDA approval for treatment of epilepsy

U.S. Centers for Disease Control & Prevention - SARS preparedness checklist developed for state and local health officials

U.S. Food and Drug Administration - FDA to determine what low-carb means

University at Buffalo - Chronic sinusitis is an immune disorder; antifungal is effective treatment

University of Michigan - Medical privacy law makes health research harder, more expensive

Vasomedical, Inc. - EECP therapy systems receive FDA 510K clearance for revised labeling

Vion Pharmaceuticals, Inc. - Cloretazine receives Fast Track designation from FDA

eResearchTechnology, Inc. - $1.7M award for cardiac safety monitoring and services announced